Clinical Trial Update: Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update notes a Phase 2 trial evaluating psilocybin for PTSD in veterans. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Ohio State University | Conditions: PTSD, Stress Disorders, Traumatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING